ELAB Stock Analysis: Buy, Sell, or Hold?

ELAB - PMGC Holdings Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
$1.60
0.06 (3.90%) ▲
5d: -9.6%
30d: -25.92%
90d: +123.7%
HOLD
LOW Confidence
Analysis Updated: Jun 5, 2026 12:00 AM ET
Earnings: May 13, 2026 0d

Get Alerted When ELAB Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 HOLD: ELAB shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: ELAB is currently trading at $1.60, which is considered oversold relative to its 30-day fair value range of $1.67 to $2.16.

Technical Outlook: Technically, ELAB is in a downtrend. The price is currently testing key support at $1.62. A bounce from this level would confirm strength, while a break below could signal further downside. The stock is showing strong short-term momentum, up 3.9% recently.

Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position OVERSOLD
Historical Trading Range $1.67 - $2.16
Company Quality Score 49/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 86.5%

All Signals

  • BULLISH: Price oversold vs 30-day range
  • NEUTRAL: Mixed technical signals (45/100)
  • BULLISH: High volume confirmation
  • BULLISH: Strong upward momentum (+3.9%)
  • CAUTION: Recommendation downgraded due to -9.6% 5-day decline

Trading Range Analysis

30-Day Trading Range $1.67 - $2.16
Current vs Trading Range OVERSOLD

Support & Resistance Levels

Support Level $1.62
Resistance Level $1.97
Current Trend Downtrend
Technical data as of Jun 3, 2026

Fundamental Context

Revenue Growth (YoY) -45.8%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: June 08, 2026 12:51 PM ET
Data refreshes hourly during market hours. Next update: 1:51 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for ELAB.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ALNY
Alnylam Pharmaceuticals …
STRONG BUY
33 analysts
$446 60 BUY
ARGX
argenx NV ADR
STRONG BUY
22 analysts
$1023 67 BUY
SRPT
Sarepta Therapeutics Inc
STRONG BUY
26 analysts
$22 51 HOLD
INSM
Insmed Inc
STRONG BUY
21 analysts
$200 49 HOLD
DNLI
Denali Therapeutics Inc
STRONG BUY
19 analysts
$34 57 HOLD

More Analysis for ELAB

ELAB Technical Chart ELAB Price Prediction ELAB Earnings Date ELAB Investment Advisor ELAB Fair Price Analyzer ELAB Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals